Unique ID issued by UMIN | UMIN000042753 |
---|---|
Receipt number | R000048796 |
Scientific Title | Effect of Daily Ingestion of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study |
Date of disclosure of the study information | 2020/12/15 |
Last modified on | 2021/10/25 09:55:54 |
Effect of Daily Ingestion of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Beneficial Effects of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function
Effect of Daily Ingestion of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Beneficial Effects of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function
Japan |
Healthy adults
Adult |
Others
NO
To investigate clinical benefits associated with immune function on 12 weeks daily ingestion of partially hydrolyzed guar gum (PHGG) in a randomized, double-blind, placebo-controlled, parallel group study.
Safety,Efficacy
Confirmatory
Pragmatic
Diary about cold-like symptoms at 6 and 12 weeks after beginning the intake of test food.
Salivary secretory IgA, number of NK cells, CD4/CD8 ratio, number of Treg cells, serum IgG, five fraction of leukocyte, serum cytokines (IFN-gamma, IL-10), organic acids in feces.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
YES
No need to know
2
Prevention
Food |
Daily ingestion 7.2 g of Partially Hydrolyzed Guar Gum (PHGG) for 12 weeks.
Daily ingestion 7.2 g of dextrin for 12 weeks.
20 | years-old | <= |
65 | years-old | > |
Male and Female
1. Subjects who fully understand significance, content and purpose of this study and who agree to participate in this study with a written informed consent.
2. Subjects with relatively high score for 18 items related to psychological stress on The Brief Job Stress Questionnaire.
1. Subjects who are under treatment or medication for autoimmune diseases, chronic inflammatory diseases or allergies.
2. Subjects who plan to receive influenza vaccination from the screening test date to the end of intake.
3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal or affected with infectious diseases which is required to report to the authorities.
4. Subjects who have a major surgical history such as gastrectomy, gastrorrhaphy, enterectomy or other serious gastrointestinal surgeries.
5. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data.
6. Subjects with severe anemia.
7. Pre- or post-menopausal women complaining of obvious physical changes.
8. Subjects who are at risk of having allergic reactions to drugs, foods (especially soybeans or peanuts) and/or birch pollen.
9. Subjects who regularly take medicines (Antibiotics, immunosuppressants, anti-inflammatory drugs, antirheumatic drugs, antihistamines, antiallergic drugs, lactic acid bacteria preparations), functional food and/or supplements (mushrooms, seaweed, nucleic acids, yeast, lactobacillus, etc.) which would affect the immune function.
10. Heavy smokers, alcohol addicts or subjects with irregular lifestyle.
11. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks, or blood components within 2 weeks, prior to the current study.
12. Pregnant or lactating women or women who expect to be pregnant during this study.
13. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study.
14. Subjects determined to be ineligible by the principal investigator.
100
1st name | Jun |
Middle name | |
Last name | NISHIHIRA |
Hokkaido Information University
Department of Medical Management and Informatics
069-8585
59-2, Nishi-nopporo, Ebetsu, Hokkaido, Japan
011-385-4411
nishihira@do-johodai.ac.jp
1st name | Naoyuki |
Middle name | |
Last name | HONMA |
Hokkaido Information University
Health Information Science Center
069-8585
59-2, Nishi-nopporo, Ebetsu, Hokkaido, Japan
011-385-4430
hisc-acad.res@s.do-johodai.ac.jp
Hokkaido Information University
Nestle Japan Ltd.
Taiyo Kagaku Co. Ltd.
Profit organization
Japan
The ethics committee of Hokkaido Information University
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
011-385-4411
soumu@do-johodai.ac.jp
NO
北海道情報大学 保健センター(北海道)
2020 | Year | 12 | Month | 15 | Day |
Unpublished
Completed
2020 | Year | 11 | Month | 25 | Day |
2020 | Year | 11 | Month | 25 | Day |
2021 | Year | 01 | Month | 07 | Day |
2021 | Year | 04 | Month | 27 | Day |
2020 | Year | 12 | Month | 14 | Day |
2021 | Year | 10 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048796
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |